PAIGE SQUILLER: Open Payments
NPI 1306374012 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 9 payments from 5 companies in 2025. Trend: 2023 $668 · 2024 $1,127 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $398 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| ABBVIE INC. | 1 | $33 |
| PFIZER INC. | 1 | $30 |
Products named: Wegovy, AREXVY, AIRSUPRA, UBRELVY, PREVNAR 20, Saxenda.
Industry payments across CA — which companies pay providers there.
